Facilitated By

San Antonio Medical Foundation

News

  • ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with ...

    ... biotechnology company advancing therapies that boost the immune syste. ... San Antonio Breast Cancer Symposium (SABCS), which will be held in San ...

  • ALX Oncology Announces Results From Phase 1b/2 Trial Of Evorpacept In Combination ...

    ... biotechnology company advancing therapies that boost the immune ... San Antonio Breast Cancer Symposium (SABCS), which will be held in San ...

  • VIRTUE LABS NAMED TO TIME'S LIST OF THE BEST INVENTIONS OF 2024 - Le Lézard

    Virtue Labs, the biotech hair care company known for its proprietary ... San Antonio Breast Cancer Symposium. Eli Lilly and Company today ...

  • ALX Oncology Announces Results from Phase 1b/2 Trial of Evorpacept in Combination with ...

    ... San Antonio Breast Cancer Symposium (SABCS), which will be held in San ... Biotechnology & Medical Research. Calendar. 2024-11-12 - Q3 2024 ...

  • Lilly to Present Results from Phase 3 EMBER-3 Study of Imlunestrant, an Oral SERD, and ...

    ... San Antonio Breast Cancer Symposium (SABCS) taking place December 10-13 ... Harnessing the power of biotechnology, chemistry and genetic ...